Scott S Tykodi

Scott S Tykodi

UNVERIFIED PROFILE

Are you Scott S Tykodi?   Register this Author

Register author
Scott S Tykodi

Scott S Tykodi

Publications by authors named "Scott S Tykodi"

Are you Scott S Tykodi?   Register this Author

28Publications

1313Reads

20Profile Views

Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.

Cancer Immunol Immunother 2019 Nov 4. Epub 2019 Nov 4.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02419-4DOI Listing
November 2019

Gene fusion analysis in renal cell carcinoma by FusionPlex RNA-sequencing and correlations of molecular findings with clinicopathological features.

Genes Chromosomes Cancer 2019 Aug 10. Epub 2019 Aug 10.

Department of Pathology, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22798DOI Listing
August 2019

Thyroid-Like Follicular Renal Cell Carcinoma Arising Within Benign Mixed Epithelial and Stromal Tumor.

Int J Surg Pathol 2019 Jul 25:1066896919863478. Epub 2019 Jul 25.

1 University of Washington Medical Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1066896919863478DOI Listing
July 2019

Clinical Utility of Chromosome Genomic Array Testing for Unclassified and Advanced-Stage Renal Cell Carcinomas.

Arch Pathol Lab Med 2019 Apr 1;143(4):494-504. Epub 2018 Nov 1.

From the Department of Pathology, University of Washington, Seattle (Drs Andeen and Tretiakova); the Department of Pathology, Oregon Health & Science University, Portland (Dr Andeen); Cytogenetics, Seattle Cancer Care Alliance, Seattle, Washington (Dr Qu); the Department of Pathology, University of Chicago, Chicago, Illinois (Dr Antic); and the Division of Medical Oncology, Department of Medicine (Dr Tykodi), and the Department of Pathology (Dr Fang), University of Washington, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle. Drs Andeen and Qu contributed equally to this work.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2018-0104-OADOI Listing
April 2019

Patient-reported outcomes with nivolumab in advanced solid cancers.

Cancer Treat Rev 2018 Nov 2;70:75-87. Epub 2018 Aug 2.

Bristol-Myers Squibb, Rt 206 & Province Line Road, Princeton, NJ 08543, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.08.001DOI Listing
November 2018

Comparative Effectiveness of Initial Surgery vs Initial Systemic Therapy for Metastatic Kidney Cancer in the Targeted Therapy Era: Analysis of a Population-based Cohort.

Urology 2018 Mar 23;113:146-152. Epub 2017 Nov 23.

Department of Urology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.11.014DOI Listing
March 2018

A Drug Interaction Between Cabozantinib and Warfarin in a Patient With Renal Cell Carcinoma.

Clin Genitourin Cancer 2016 Feb 3;14(1):e119-21. Epub 2015 Oct 3.

Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.09.015DOI Listing
February 2016

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.

N Engl J Med 2015 Nov 25;373(19):1803-13. Epub 2015 Sep 25.

From Memorial Sloan Kettering Cancer Center, New York (R.J.M.), and Roswell Park Cancer Institute, Buffalo (S.G.) - both in New York; Institut Gustave Roussy, Villejuif (B.E.), and Bordeaux University Hospital, Hôpital Saint André, Bordeaux (A.R.) - both in France; Beth Israel Deaconess Medical Center (D.F.M.) and Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School (T.K.C.) - all in Boston; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (H.J.H.); Stanford Cancer Institute, Stanford, CA (S.S.); University of Washington and Fred Hutchinson Cancer Research Center, Seattle (S.S.T.); Vanderbilt University Medical Center, Nashville (J.A.S.); Fondazione Istituto Nazionale Tumori, Milan (G.P.); Fox Chase Cancer Center, Philadelphia (E.R.P.); Hospital Universitario 12 De Octubre, Madrid (D.C.); Westmead Hospital and Macquarie University, Sydney (H.G.); Aarhus University Hospital, Aarhus, Denmark (F.D.); Helsinki University Central Hospital and University of Helsinki, Helsinki (P.B.); South West Wales Cancer Institute and Swansea University College of Medicine, Swansea (J.W.), and Royal Marsden Hospital, London (J.L.) - both in the United Kingdom; University Hospital Essen of University of Duisburg-Essen, Germany (T.C.G.); Chiba Cancer Center, Chiba (T.U.), and Niigata University, Niigata (Y.T.) - both in Japan; Hospital Sao Jose, Beneficencia Portuguesa de São Paulo, São Paulo (F.A.S.); British Columbia Cancer Agency, Vancouver, BC, Canada (C.K.); Bristol-Myers Squibb, Lawrenceville (J.S.S., I.M.W.) and Hopewell (L.-A.X.) - both in New Jersey; and M.D. Anderson Cancer Center, University of Texas, Houston (P.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1510665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719487PMC
November 2015

Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy Era.

Urology 2015 Aug 18;86(2):262-8. Epub 2015 Jul 18.

Department of Urology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2015.05.008DOI Listing
August 2015

Systemic therapy of metastatic melanoma: on the road to cure.

Oncology (Williston Park) 2015 Feb;29(2):126-35

View Article

Download full-text PDF

Source
February 2015

PD-1 as an emerging therapeutic target in renal cell carcinoma: current evidence.

Authors:
Scott S Tykodi

Onco Targets Ther 2014 25;7:1349-59. Epub 2014 Jul 25.

Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S48443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122552PMC
August 2014

HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.

J Immunol 2013 Aug 12;191(4):1567-77. Epub 2013 Jul 12.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1300080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732835PMC
August 2013

Progress and potential of immune checkpoint blockade for treating advanced renal cell carcinoma.

Authors:
Scott S Tykodi

Immunotherapy 2013 Jun;5(6):607-19

Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA 98109-1023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.13.39DOI Listing
June 2013

Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after.

Expert Opin Biol Ther 2011 Jun 21;11(6):763-73. Epub 2011 Mar 21.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2011.566855DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201801PMC
June 2011

Treatment of metastatic melanoma: an overview.

Oncology (Williston Park) 2009 May;23(6):488-96

Department of Medicine, Division of Medical Oncology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737459PMC
May 2009

Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer.

Expert Opin Biol Ther 2008 Dec;8(12):1947-53

Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Mailstop G4-830, Seattle, WA 98109-1023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712590802567298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592504PMC
December 2008

An antigen produced by splicing of noncontiguous peptides in the reverse order.

Science 2006 Sep;313(5792):1444-7

Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.1130660DOI Listing
September 2006